Uncoupled collagen synthesis and degradation assays
AssigneeBarnes-Jewish Hospital
InventorsLinda J. Sandell, Patrick Garnero
Life of this patent
Estimating the term…
Loading patent…
AssigneeBarnes-Jewish Hospital
InventorsLinda J. Sandell, Patrick Garnero
Estimating the term…
The invention relates to methods for determining the progression of cartilage degeneration diseases, such as osteoarthrits and rheumatoid arthritis, by quantitating collagen synthesis and degradation markers in patient samples. One can determine whether a cartilage degeneration condition is progressing, regressing, or remaining stable by quantitating collagen synthesis and degradation markers in patient samples and comparing the value obtained to a reference value. When a joint affected by cartilage degeneration in question expresses collagen synthesis and degradation markers, a change in this value is indicative of a change in the progression of the cartilage degeneration condition. The methods and apparatus of the invention allow accurate determination of the therapeutic effects certain cartilage degeneration drug treatments, including osteoarthritis and rheumatoid arthritis drug treatments, so are also useful for pharmaceutical efficacy studies in mammals.
A method for detecting or predicting cartilage destruction in a subject, said method comprising detecting an uncoupling of type II collagen synthesis from type II collagen degradation in the subject.
A method for determining the progress of osteoarthritis or cartilage destruction in a subject, said method comprising quantifying an uncoupling of type II collagen synthesis from type II collagen degradation in the subject.
A method for detecting or predicting osteoarthritis in a subject, the method comprising the steps of:
A method for detecting or predicting osteoarthritis in a subject, the method comprising the steps of:
A solid support in contact with a combination of a first antibody and second antibody, wherein the first antibody is capable of specifically binding to a human collagen synthesis marker and the second antibody is capable of specifically binding to a human collagen degradation marker.
A kit for detecting the progression of osteoarthritis comprising instructions setting forth a method comprising the following:
Dependencies are inferred from the claim text.